The COVID-19 Vaccine, Explained by Cornell Virologists

As COVID-19 cases continue to spike across the United States and the rest of the world, several pharmaceutical companies have reached their final lap in the race to approve and distribute a COVID-19 vaccine — a vaccine from Pfizer and BioNTech received emergency authorization from the Food and Drug Administration on Dec. 11, and the FDA is expected to authorize Moderna’s vaccine by the end of the month.

Cornell Researchers Collaborate to Investigate Environmental Consequences of Hydropower Dams

The Amazon River Basin is under threat, largely at the hands of humans. To help change that, Prof. Carla Gomes, computer science, Prof. Alexander Flecker, ecology and evolutionary biology, and Rafael Almeida, postdoctoral researcher with the Atkinson Center for a Sustainable Future, designed an interdisciplinary research project to inform policymakers of the environmental consequences of human actions.

How Cornell Adopts a Multidisciplinary Approach In Tackling Breast Cancer

Each October, Americans honor their loved ones battling breast cancer with charity fundraisers, pink clothing items and ribbons. Breast Cancer Awareness Month often comes as a somber reminder of lives lost to the devastating disease and all that researchers have yet to understand. But what exactly is breast cancer, and how can it currently be treated?